1、Expression anlysis
1.1、ANKRD6 expression in cancers was analyzed with the Oncomine database (https://www.oncomine.org/resource/login.html)
1.2、The differential expression of ANKRD6 mRNA between tumor and normal tissues was analyzed by TIMER (TCGA gene expression RNA-seq data)
1.3、The differential expression of ANKRD6 mRNA between tumor and normal tissues was analyzed by GEPIA.
2、Prognosis anlysis
2.1、Based on the Affymetrix microarray, we used PrognoScan technology to study the relationship between ANKRD6 expression and the prognosis of different cancers.
2.2、TCGA-RNA sequencing data were also used to analyze the prognostic potential of ANKRD6 in different cancers by GEPIA
3、Immune infiltration anlysis
3.1、Using TIMER, we investigated the correlations between ANKRD6 expression and immune infiltration levels.
3.2、Using the CIBERSORT algorithm, we evaluated the abundance of TILs in the colon microenvironment using the TCGA gene expression data
3.3、We used IHC to analysis the correlation between different ANKRD6 expression levels and OS and M2 macrophages in colon cancer(CD68, CD163 and ANKRD6)
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.